全身炎症反应指数与颅内梭形动脉瘤瘤壁强化及预后相关
本研究回顾性分析92例颅内梭形动脉瘤患者,探讨血液炎症指数与高分辨率磁共振瘤壁强化(3D-AWEavg)及长期预后的关系。结果显示SIRI独立预测3D-AWEavg,SIRI与3D-AWEavg均可预测总体不良结局。高SIRI(≥0.725×10⁹/L)或3D-AWEavg≥0.604者不良结局风险显著升高。
要点
- SIRI可独立预测颅内梭形动脉瘤的瘤壁强化程度,提示瘤壁炎症状态。
- SIRI≥0.725×10⁹/L或3D-AWEavg≥0.604时不良结局风险显著增加。
- 血液炎症指数SIRI可作为颅内梭形动脉瘤风险分层的潜在生物标志物。
核心结论
- SIRI可同时预测颅内梭形动脉瘤的瘤壁强化和长期不良结局,支持其作为风险分层和临床决策的新型生物标志物。
研究设计与样本
- 回顾性研究,来自维护的数据库,纳入接受高分辨率磁共振成像和血液实验室检查的颅内梭形动脉瘤患者。
- 横断面研究纳入92例患者,随访研究纳入64例患者,平均随访29.27个月。
关键影像表现/征象
- 高分辨率磁共振显示的瘤壁强化(AWE)作为动脉瘤不稳定的影像生物标志物,反映瘤壁内炎症。
- 3D-AWEavg为三维方向上动脉瘤瘤壁强化的平均值,用于量化瘤壁炎症程度。
诊断标准与关键数值
- SIRI独立预测3D-AWEavg(P = 1.1 × 10⁻⁵)。
- SIRI预测总体不良结局(CAO):13.725(2.467-76.349),P = .003。
- 3D-AWEavg预测总体不良结局(CAO):5.387(1.320-21.988),P = .019。
- 高SIRI值(≥0.725 × 10⁹/L,log-rank = 0.002)时不良结局风险显著升高。
- 3D-AWEavg ≥ 0.604(log-rank = 3 × 10⁻⁵)时不良结局风险显著升高。
临床应用与阅片要点
- 阅片时对颅内梭形动脉瘤应关注高分辨率磁共振瘤壁强化程度,3D-AWEavg≥0.604提示预后不良。
- 可结合血液SIRI值辅助评估颅内梭形动脉瘤的炎症状态与风险分层。
局限性
- 回顾性设计,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Inflammation plays a crucial role in the pathophysiology of intracranial aneurysms (IAs). Our previous research demonstrated that blood inflammatory indices can serve as predictors of aneurysmal wall enhancement (AWE), which signifies the presence of inflammation within the aneurysmal wall and functions as an imaging biomarker for IA instability. Here, we aimed to further examine the relationship between blood inflammatory indices, AWE, and long-term clinical outcomes in patients with intracranial fusiform aneurysms (IFAs).
MATERIALS AND METHODS: We reviewed patients with IFAs who underwent high-resolution magnetic resonance imaging and blood laboratory tests, as recorded in our maintained database. Initially, a cross-sectional study was conducted to identify potential blood inflammatory indices that could predict the average value of aneurysmal wall enhancement in three dimensions (3D-AWEavg). Subsequently, a follow-up study was performed to further elucidate the potential predictors associated with overall poor outcomes (CAO) in the same cohort.
RESULTS: A total of 92 patients were included in the cross-sectional study. Both the systemic inflammation response index (SIRI), the systemic immune-inflammation index (SII), and the neutrophil-to-lymphocyte ratio (NLR) were associated with 3D-AWEavg in univariate analysis; however, only SIRI was found to independently predict 3D-AWEavg (P = 1.1 × 10-5). In the follow-up study, 64 patients were included, with a mean follow-up period of 29.27 months. SIRI (13.725 [2.467-76.349], P = .003) and 3D-AWEavg (5.387 [1.320-21.988], P = .019) were identified as the predictors of CAO in patients with IFAs. Furthermore, patients with a high SIRI value (≥0.725 × 109/L, log-rank = 0.002) or a 3D-AWEavg ≥ 0.604 (log-rank = 3 × 10-5) had significantly higher risk of CAO.
CONCLUSION: SIRI predicts both aneurysmal wall enhancement and long-term adverse outcomes in patients with IFAs, supporting its potential role as a novel biomarker for risk stratification and clinical decision-making in this population.
引用
- Kang, Peng, Wang, et al. Systemic Inflammation Response Index May Be Associated with Aneurysmal Wall Enhancement and Overall Poor Outcomes in Patients with Intracranial Fusiform Aneurysms. Acad Radiol. 2026. PMID: 41577515. doi:10.1016/j.acra.2026.01.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。